Sarah James
Stock Analyst at Cantor Fitzgerald
(0.82)
# 2337
Out of 5,364 analysts
297
Total ratings
29.77%
Success rate
-1.81%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HUM Humana | Reiterates: Neutral | 290 290 | 232.44 | 24.76% | 21 | May 1, 2025 | |
ELV Elevance Health | Reiterates: Overweight | 485 485 | 381.5 | 27.13% | 20 | Apr 23, 2025 | |
CI Cigna Group | Maintains: Overweight | 350 365 | 312.18 | 16.92% | 21 | Mar 20, 2025 | |
TBRG TruBridge | Maintains: Overweight | 20 29 | 25.06 | 15.72% | 6 | Mar 11, 2025 | |
LFMD LifeMD | Reiterates: Overweight | 15 15 | 12.66 | 18.48% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 177 177 | 161.83 | 9.37% | 20 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 368.06 | 10.04% | 19 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 700 700 | 307.65 | 127.53% | 17 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 90 90 | 55.3 | 62.75% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 52 52 | 22.71 | 128.97% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 17 | 22 | -22.73% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 219 219 | 173.2 | 26.44% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 406 406 | 293.14 | 38.5% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 43 43 | 23.32 | 84.39% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 4.01 | 299% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 62 62 | 65.32 | -5.08% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.53 | 226.8% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 7.45 | 34.23% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 101 101 | 96.98 | 4.15% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 133 | 137.86 | -3.53% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 42 | 22.38 | 87.67% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 3.81 | 31.23% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 5 | 5.38 | -7.06% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 34 | n/a | n/a | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 57 | n/a | n/a | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 21 | 15.33 | 36.99% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 15 18 | n/a | n/a | 2 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 39 | 58.59 | -33.44% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 212 206 | n/a | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 151 0 | n/a | n/a | 2 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 193 | 70.88 | 172.29% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Mar 1, 2017 |